Pre-surgical antibody treatment might prevent heart transplant rejection

Estimated reading time: 1 minutes

• About The Author

Anti-rejection regimens currently in use are broad immunosuppressive agents that make patients susceptible to infections. By using specific antibodies, it may be possible to just block the inflammation that leads to rejection but leave anti-microbial immunity intact.

About The Author

See author's posts

Trending

Why Young Athletes Should Care About Joint Health Early On